What is the event about?
Imperial Collider returns, providing you the opportunity to meet world-leading researchers across Imperial’s health and innovation ecosystem. Come along to hear from startup and spinout founders from our community, representatives from funding and investment organisations, and leading industry figures in health, pharma and biosciences.
This year, our keynote speaker is Dr Fiona Marshall, President of Biomedical Research at Novartis, who will bring her extensive experience and cross-cutting expertise to inspire impact-making innovation throughout the community.
What is the agenda?
- Full agenda available on Eventbrite
What can you expect to take away from our event?
- Direct access to top voices in biomedical innovation from Imperial, pharma, investment, and translational research.
- High-value networking opportunities with academics, founders, funders, and R&D leaders.
- Practical insight into the biomedical sector landscape, including key trends, partnerships, funding, and innovation pathways.
- Real examples of translational success, including topics like GLP biology, rhinovirus vaccines, antimicrobial resistance, precision medicine, and digital health.
- Strong emphasis on partnership-building, helping attendees identify collaborators and routes to commercial or clinical impact.
- Relevant for both early-career and senior attendees, whether they are seeking funding, industry links, research partners, or strategic insight.
How will you benefit from our matchmaking experience?
PartneringONE is a powerful online platform that will enable speed meetings in advance.
- Targeted matchmaking through a full day of curated 1:1 speed meetings.
- Efficient, high-value conversations with each meeting lasting 25 minutes, ideal for focused introductions and opportunity scouting.
- Dedicated online partnering platform for a smooth and structured meeting experience.
- Advance profile browsing so participants can identify the most relevant organisations and individuals before the event.
- Pre-scheduled tailored agendas that maximise time, relevance, and meeting outcomes.
- Streamlined networking experience combining smart planning tools with productive live interactions.
Who should attend?
-
Imperial academics and researchers working in pharmaceuticals, drug discovery, healthcare and medtech
-
Early career researchers at Imperial are looking for industry partners or support in applying for grants and funding
-
Research and development leaders at medical companies are looking for an academic partner or inspiration on breakthrough areas of science
What else do I need to know?
- Please complete your registration in full to confirm your job title, company, and dietary and accessibility requirements.
- This is a ticketed event with limited space. We reserve the right to cancel your ticket.
- There will be photography and filming at this event.
- For venue accessibility information, please contact Prashanthini (Prasshy) Jeyarajan: p.jeyarajan@imperial.ac.uk
- All guests registering for this event will be expected to adhere to Imperial’s Institutional Events code of conduct.
- Please return all digital/print lanyards, or a fine may be incurred.
- Imperial College London – Enterprise Division Privacy Notice
For all other questions, please contact Prashanthini (Prasshy) Jeyarajan: p.jeyarajan@imperial.ac.uk
Who is sponsoring Imperial Collider: Health 2026?
HSBC Innovation Banking partners with high-growth venture-backed tech and life science businesses and their investors to build banking solutions that evolve as their ambitions, needs and footprint grow. Its Early-Stage Banking team offers pre-seed to Series A businesses startup expertise, ecosystem connections and scalable banking services to help them reach their Series A and beyond.